Poland The value of Poland’s pharmaceutical exports shot from USD 501 million in 2005 to USD 3.475 billion in 2015, a total growth of an astounding 590% and a compound annual growth rate of 21%. Most exports go to Europe (80%) but Asian markets are becoming increasingly important to Poland and…

Poland The Top 20 pharma companies in the Polish retail market for 2017 ranked by sales in USD millions. Domestic champion Polpharma leads the way, followed by international players Teva and Bayer.

China The Greater Bay Area (several cities in Guangdong Province in mainland China along with Hong Kong and Macau) is a major Chinese government scheme to link the entire region into an integrated economic and business hub . The Greater Bay Area, taken as a whole, dwarfs the world’s other major…

Baltics In terms of being able to access medicines, patients in the Baltic states fare poorly compared to many of their European counterparts. 135 new medicines were approved by regulators in Lithuania and Estonia in 2016, but only 38 and 30 were made available to patients respectively. Latvia fares even worse,…

Latvia The top 20 companies in the Latvian pharmaceutical market for 2017, sorted by total value and market share, with data on year-on-year growth. American giant AbbVie ranks first, with an almost six percent market share and astounding 65 percent year-on-year growth, followed by TEVA and Sanofi.

India India’s pharmaceutical sales and forecast from 2013 up to 2021. Between 2017 and 2021, the Indian pharma market is forecasted to grow by a CAGR of between nine and ten percent. The Indian biotechnology market grew by a CAGR of 20.33% between 2005 and 2015 and stood at USD 11.6…

India The top 15 pharma companies in India for 2017 ranked by market share and growth rate. Homegrown champions Sun Pharma, Cipla and Zydus Cadila lead the way with 5.5, 4.6 and 3.9% market shares respectively.

Lithuania Lithuania’s key economic indicators between 2015 and 2018: GDP growth, inflation, unemployment rate, and government budget. Lithuania’s pharma market in terms of both volume and value. Spending on public health in Lithuania. The Lithuanian pharma market split by dispensing types. The public funding of health and pharmaceuticals in Lithuania. Healthcare…

Lithuania The Top 20 pharma companies in Lithuania by value for 2017. J&J leads the way with a value of around EUR 35 million and market share of 6.3% bolstered by 63% year-on-year growth. Berin Chemie ranks second, while Novartis ranks third.

Pharma India leads the way in terms of the sheer volume of US FDA-approved manufacturing plants with over 100, compared to only 28 in China. In terms of the global competitiveness of Brazil, Russia, India, China and South Africa (BRICS), China remained out in front between 2012 and 2015, with India…

Brazil The Top 20 pharma companies in Brazil for 2017, combining the data for both the retail and non-retail markets. Sanofi leads the way, followed by local player NC Farma and Hypermarcas.

Brazil The Latin American pharmaceutical market in comparison. Brazil is by far the largest market. GDP real growth in Latin America regional comparison. Top 20 pharma companies in Latin America. Sanofi leads the way followed by Novartis and GSK. Brazil GDP and pharmaceutical market growth between 2014 and 2017. The evolution…